Ọrịa hypolipPs Tricor: ntuziaka maka ojiji, ọnụahịa, nyocha na analogues nke ọgwụ

Mpempe mkpụrụ akwụkwọ edere Tricor ma ọ bụ 145 na 160 mg nke ihe dị n'ọrụ n'ụdị fenofibrate.

Banyere ihe eji eme ọgwụ, ọ na - agbadata ume ala (ma ọ bụ wedata mkpo nke lipids). Ọgwụ a bụ nke otu ọgwụ ọgwụ fibrates.

Omume General

N'ụzọ bụ isi, a na-eji ọgwụ ahụ eme ihe maka ọrịa na-ejikọta:

• yana ma insulin-based na-abụghị insulin-based pathologies nke ọrịa shuga mellitus;
• ya na hypercholesterolemia (cholesterol dị n'ọbara), hyperglyceridemia (triglycerides na-akpata oke ibu);
• ya na ọrịa hyperlipidemia agwakọta (ọkwa ọbara dị elu nke cholesterol na abụba na triglyceride);
• yana ọrịa hyperlipidemia ndị ọzọ.

Maka ozi banyere otu nke Tricor n'otu otu ụlọ ọgwụ na ọgwụ ọgwụ, ndị nrụpụta ntuziaka Recipharm Monts, yana Laboratoies Fournier S.A. ọ bụ anọghị ya.

Omume ọgwụ na ihe ngosi

N'oge ọnwụnwa nke Tricor ọgwụ ozugbo na ụlọọgwụ, ọmụmụ gbasara ndị ọrịa kpughere na site na enyemaka nke fenofibrate, a na-ebelata ọkwa nke cholesterol na 20 site na 20, ma ọ bụ karịa 25%, yana n'ihe banyere iweda ha triglycerides, ihe ngosi a sitere na 40 na 55%.

Erere Tricor 145 mg

Ọzọkwa, n'ime ndị ọrịa nwere hypercholesterolemia, ngụkọta nke mkpokọta na cholesterol LDL na-ebelata. Ekwesiri iburu n'uche na ogo a bụ otu n'ime mkpebi nke oke ihe ize ndụ nke ọrịa obi obi.

Ọgwụ gosipụtara dị ka njikọta na ọgwụgwọ na-abụghị ọgwụ. Maka ndị dị ka usoro mmega ahụ dị iche iche, ụzọ maka oke ibu, yana iji nri maka ọrịa:

• oké ọbara ọgbụgba;
• hyperlipidemia agwakọtara, ma ọ bụrụ na enwere contraindications maka statins (ọgwụ ndị na-ebelata cholesterol n'ime ọbara);
• gwakọtara hyperlipidimia. Mgbe ndị ọrịa nwere nnukwu ihe ize ndụ nke ma ọrịa obi na ọrịa akwara;
• na kwa mbadamba ụrọ ka etinyere n’ihu ọrịa shuga mellitus n’ihe banyere nri na mmega ahụ anaghị arụ ọrụ.

Ọgwụgwọ ọgwụgwọ

Fenofibrate bụ ihe sitere na fibric acid. Ọ na-agbanwe ruru nke lipids n’ime ọbara.

N'oge usoro ọgwụgwọ, a na-ahụ mgbanwe ndị a:

• nwepu onwu ma obu nhicha ọbara;
• n'ime ndị ọrịa nwere ihe ize ndụ nke CHD, ọkwa liheprotiins atherogenic na-ebelata (ruru, nke na-abawanye n'ihe ize ndụ nke atherosclerosis) ma ọ bụ cholesterol “ọjọọ”;
• na-akwalite mmụba nke cholesterol dị mma ";
• ike nke itinye intravascular edebe belata belata;
• ọkwa fibriogen na-ebelata;
• ọbara na-ebelata ihe ndị dị na uric acid, yana protein C-reactive action na plasma ya.

Oke ọdịnaya fenofibrate na ọbara na-apụta n'ime awa ole na ole mgbe ọ nwesịrị Onye Ọrịa.

A ga-ewepụ ya kpamkpam n'ime ụbọchị 6-7 kachasị na mmamịrị. N'otu oge, fenofibrate anaghị apụ apụ n'oge a na-agwọ ya, ebe ọ bụ na o yiri ka ọ na-ejikọ plasma albumin (protein bụ isi).

Ihe ngbanwe

Ndepụta contraindications nke amatagoro n’ime usoro nyocha, yana omume nke itinye Treycor, bụ:

• ihe di elu nke uche ya mejuputa fenofibrate, yana ndi ozo nke ogwu ahu;
• hepatic, ọdịda akụrụngwa;
• n'ọbara;
• afọ erughị afọ 18;
• photoensitivity (nwetakịrị uche nke akpụkpọ ahụ mucous na akpụkpọ ahụ ma ultraviolet na radieshon na-ahụ anya), yana fototoxicity;
• ọrịa ọnya afọ;
• Ngosiputa ahuhu ahuhu n’anu ahuhu na mmanu ya, ka ngwaahịa nke soy, nke ekpughere n’iru ichikota anamnesis ma obu juo onye oria anya tupu ya edee ogwu;
• lactation.

Iji nlezianya debe Tricor mgbe onye ọrịa ahụ:

• na-a alcoholụbiga mmanya ókè;
• na-arịa ọrịa hypothyroidism ma ọ bụ nwee ụkọ nke homonụ thyroid;
• na agadi;
• na-arịa ọrịa akwara ndị e ketara eketa.

Ime

Ma ihe omuma banyere nnwale nke ulo ogwu na n’eji iji ogwu eme ihe site na umunwanyi di ime ezughi.

Dịka ọmụmaatụ, na nnwale na ụmụ anụmanụ, a chọpụtaghị uto nke tetratogenic (mmepe nke ẹmbrayo nwa n’okpuru mmetụta ọgwụ).

Na usoro nke nnwale, a gosipụtara afọ iri n’afọ n’ihi ọgwụ otu n’ime ụmụ nwanyị dị ime ji nnukwu ọgwụ ọgwụ. Agbanyeghị, ihe aka dịịrị ndị inyom dị ime egobeghị nke ọma.

Usoro onunu ogwu na ubochi

A na-ewere ọgwụ ahụ n'ọnụ, mgbe ị na-asa mmiri mbadamba nkume. Oge inyoghi inabata na esighi n’elu nri (Tricor 145). Ekwesiri iji cheta Tricorr 160 kwesịrị iji otu oge eme ya.

Ọgwụ maka ndị ọrịa bụ mbadamba 1 kwa ụbọchị.

Ọzọkwa, ọ bụrụ na ndị ọrịa na mbụ eburu mbadamba ọgwụ 160 nke Tricor, mgbe ahụ ha nwere ike, ma ọ bụrụ na ọ dị mkpa, gbanwee ị takingụ ọgwụ milligram 145, na enweghị mmezi dose. Ndị ọrịa n’oge agadi kwesịrị ị doseụ otu ahịrị - ọ bụghị ihe karịrị 1 mbadamba kwa ụbọchị otu ugboro.

Ọgwụ nwere ogologo oge eji, ebe ịkwesịrị ịgbasochi nri enyere gị na mbụ. Ekwesiri iji nyocha nke arụmọrụ ọgwụ Tricoror naanị site n'aka dọkịta na-aga ya mgbe ị na-enyocha ọdịnaya nke lipids (abụba na ihe ndị yiri ya), na LDL, cholesterol ngụkọta, yana ọdịnaya nke triglycerides.

N'ihe banyere mgbe ọtụtụ ọnwa adịghị ahụcha ọgwụgwọ, anaghị ahụ ụzọ nhọrọ ọgwụgwọ ọzọ.

Njikọ Ọgwụ

Fenofibrate mgbe ejikọtara ya na ọgwụ anticoagulants na-egbu egbu (ọgwụ na-ewepụ thrombosis) na-eme ka mmetụta nke ikpeazụ ahụ kawanye ohere nke ọbara ọgbụgba, nke bụ n'ihi na ọgwụ antithrombotic na-abụkarị site na saịtị ndị ahụ na-enwekarị protein na-egbochi plasma ọbara.

Yabụ, na mmalite ọgwụgwọ yana fenofibrate, mmadụ kwesịrị ibelata oriri ọgwụ dị otu ụzọ n'ụzọ atọ ma mesịa jiri nwayọ họrọ nke kachasị dị ka ọkwa nke INR (ọkwa mba ụwa si dị). Banyere njikọta na ọgwụ dịka Cyclosporine, enwere n'ọtụtụ ọnọdụ nke nsonaazụ dị egwu nke nchịkwa ya yana fenofibrate.

Ọ bụrụ na nke a dị mkpa, mgbe ahụ ọ dị mkpa iji nyochaa ọrụ nke imeju, wee gbanwee mgbanwe na nyocha ya pụtara, wepụ Tricor ozugbo. Ndị ọrịa ọrịa hyperlipodemia, na-a takingụ ọgwụ hormonal ma ọ bụ ọgwụ mgbochi, kwesịrị ịchọpụta ụdị ọrịa a, ebe ọ nwere ike ịbụ nke mbụ ma ọ bụ nke abụọ.

Banyere ụdị ọrịa nke abụọ, enwere ike ibute ya site na ịrogenụ mmiri estrogen, nke na-egosi na ihe ụfọdụ bụ ihe anamnesis ma ọ bụ ajụjụ ndị ọrịa jụrụ.

Mgbe ụfọdụ, mgbe eji Tricor jiri ọgwụ ụfọdụ, mmụba na transaminase (ndị a bụ enzymes n'ime sel nke na-ebufe amino acid) na imeju..

N'otu oge, enwere nkọwa nke mgbagwoju anya na iwere Tricor n'ụdị pancreatitis. A na - ejikọta usoro mkpali ndị a na mmetụta ọgwụ kpọmkwem, yana ọnụnọ nke okwute ma ọ bụ nguzobe nke ụdị n'ụdị siri ike na gallbladder, nke na-egbochi ọrụ nkịtị nke dule kele.

Ọrịa nwere ọrịa misopathy (ọrịa nje akwara na-eketa eketa), yana ndị okenye karịa afọ iri asaa, nwere ike nwee ngosipụta nke rhabdomyolysis (ọrịa nke mbibi nke akwara akwara) n'ihi nsonaazụ fenofibrate.

Ebumnuche nke ọgwụ ahụ bụ ihe ziri ezi mgbe mmetụta nke ọgwụgwọ dị elu karịa ihe egwu na nsonaazụ nke rhabdomyolysis.

Ọnụ ego na analogues

Ọnụahịa nke Tricor dị na ụlọ ahịa ọgwụ nwere ike ịdị 500 na ruo 850 rubles, dabere na oke (145 ma ọ bụ 160 mg) na oke, yana ndị na-emepụta ya. Ọzọkwa, ọnụahịa ọnụahịa ahụ nwere ike ịdị iche iche site na ọnụego egosiri na saịtị ahịa ọgwụ.

Dika analogues nke Tricor, ogwu dika:

• Innogem
• Lipofem;
• Lipicard
• Lipanorm.

Ha dị ọnụ ala karịa Tricor, ha nwere ndepụta ha nke contraindications, yana usoro onunu ogwu, nke dọkịta gha aghaghi ikpebi ya. Onweghi nnwere onwe ha.

Ihe omumu: ndi nyocha

Nyocha banyere ọgwụ Tricor na-akacha mma:

• Yuri, Lipetsk, 46 afọ. Banyere shuga, ọ naghị ebelata ya, Tricor na-alụ ọgụ cholesterol nke ọma. Agbanyeghị, achọrọ njikwa site na iji biochemistry;
• Elena, Belgorod, 38 afọ. Ọnọdụ izugbe adịla mma. Anọwo m na-aillsụ ọgwụ ruo ihe dị ka otu ọnwa ugbu a, ọ dị ka enwere m oke ibu. N’oge na-adịghị anya, nkwụsi ike nke dọkịta, a ga-anwale m. Ana m atụ anya oge nnabata nke ọnwa atọ;
• Boris, Moscow, 55 afọ. M na-a theụ ọgwụ Tricor na ọmụmụ nke ọnwa 3. Irè n’okwu m belata triglycerides.

Vidiyo ndị metụtara

Ihe ịchọrọ ịma gbasara Tricor na vidiyo a: